Ameritas Investment Partners’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18.2K | Hold |
18,512
| – | – | ﹤0.01% | 2703 |
|
2025
Q1 | $26.7K | Hold |
18,512
| – | – | ﹤0.01% | 2423 |
|
2024
Q4 | $40.7K | Hold |
18,512
| – | – | ﹤0.01% | 2307 |
|
2024
Q3 | $30.5K | Hold |
18,512
| – | – | ﹤0.01% | 2452 |
|
2024
Q2 | $41.1K | Buy |
+18,512
| New | +$41.1K | ﹤0.01% | 2245 |
|
2023
Q2 | – | Sell |
-5,765
| Closed | -$9.17K | – | 3140 |
|
2023
Q1 | $9.17K | Hold |
5,765
| – | – | ﹤0.01% | 2753 |
|
2022
Q4 | $38.6K | Buy |
5,765
+1,285
| +29% | +$8.6K | ﹤0.01% | 2236 |
|
2022
Q3 | $30K | Hold |
4,480
| – | – | ﹤0.01% | 2301 |
|
2022
Q2 | $28K | Hold |
4,480
| – | – | ﹤0.01% | 2359 |
|
2022
Q1 | $21K | Buy |
4,480
+2,207
| +97% | +$10.3K | ﹤0.01% | 2539 |
|
2021
Q4 | $11K | Hold |
2,273
| – | – | ﹤0.01% | 2861 |
|
2021
Q3 | $27K | Hold |
2,273
| – | – | ﹤0.01% | 2528 |
|
2021
Q2 | $48K | Hold |
2,273
| – | – | ﹤0.01% | 2211 |
|
2021
Q1 | $64K | Hold |
2,273
| – | – | ﹤0.01% | 1931 |
|
2020
Q4 | $59K | Hold |
2,273
| – | – | ﹤0.01% | 1882 |
|
2020
Q3 | $84K | Hold |
2,273
| – | – | ﹤0.01% | 1539 |
|
2020
Q2 | $117K | Hold |
2,273
| – | – | 0.01% | 1317 |
|
2020
Q1 | $72K | Buy |
2,273
+107
| +5% | +$3.39K | ﹤0.01% | 1453 |
|
2019
Q4 | $129K | Buy |
2,166
+173
| +9% | +$10.3K | 0.01% | 1359 |
|
2019
Q3 | $73K | Hold |
1,993
| – | – | ﹤0.01% | 1655 |
|
2019
Q2 | $93K | Hold |
1,993
| – | – | ﹤0.01% | 1540 |
|
2019
Q1 | $80K | Hold |
1,993
| – | – | ﹤0.01% | 1608 |
|
2018
Q4 | $92K | Hold |
1,993
| – | – | 0.01% | 1440 |
|
2018
Q3 | $88K | Hold |
1,993
| – | – | ﹤0.01% | 1658 |
|
2018
Q2 | $78K | Buy |
1,993
+548
| +38% | +$21.4K | ﹤0.01% | 1698 |
|
2018
Q1 | $105K | Buy |
1,445
+135
| +10% | +$9.81K | 0.01% | 1456 |
|
2017
Q4 | $86K | Hold |
1,310
| – | – | ﹤0.01% | 1585 |
|
2017
Q3 | $64K | Hold |
1,310
| – | – | ﹤0.01% | 1724 |
|
2017
Q2 | $61K | Buy |
1,310
+297
| +29% | +$13.8K | ﹤0.01% | 1772 |
|
2017
Q1 | $36K | Buy |
+1,013
| New | +$36K | ﹤0.01% | 2047 |
|